Effects of Astragalus injection and Salvia Miltiorrhiza injection on serum inflammatory markers in patients with stable coronary heart disease: a randomized controlled trial protocol
This study will employ the randomized, blinded, prospective, single-center experiments approach. Briefly, a total of 160 eligible patients will be equally randomized into three treatment groups and placebo control groups. Patients will receive appropriate treatments every 24  h for seven days after enrollment and followed up for 28 days. The main evaluation indicators will be cell count, serum high-sensitivity C-reactive protein (hs-CRP) level, monocyte chemoattractant protein 1 (MCP-1), interleukin-6 (IL-6), interleukin-1β (IL-1β), interleukin-8 (IL-8), interle ukin-18 (IL-18), interleukin-1...
Source: Trials - March 17, 2020 Category: Research Source Type: clinical trials

Study of Obesity Control by Astragalus and Notoginseng Extrats
Condition:   Obesity Interventions:   Dietary Supplement: InnoSlim;   Dietary Supplement: Placebo Sponsor:   Chung Shan Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 31, 2018 Category: Research Source Type: clinical trials

Efficacy, Safety and Response Predictors of Adjuvant Astragalus Therapy for Diabetic Kidney Disease
Conditions:   Diabetic Nephropathies;   Diabetic Kidney Disease Interventions:   Drug: Astragalus Powder;   Other: Routine medical care (active comparator) Sponsors:   The University of Hong Kong;   School of Chinese Medicine, The University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Astragalus Membranaceus on Aneurysmal Subarachnoid Hemorrhage
Condition:   Aneurysmal Subarachnoid Hemorrhage Interventions:   Drug: Astragalus Membranaceus;   Drug: Placebo Sponsor:   China Medical University Hospital Not yet recruiting - verified August 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 21, 2017 Category: Research Source Type: clinical trials

Effects of PG2 on Fatigue-Related Symptom Clusters
Condition:   Cancer-related FatigueInterventions:   Drug: Astragalus Polysaccharides 500 mg;   Drug: Astragalus Polysaccharides 250 mgSponsor:   Taipei Medical UniversityRecruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2016 Category: Research Source Type: clinical trials

Effects of PG2 on Fatigue-Related Symptom Clusters
Condition:   Cancer-related FatigueInterventions:   Drug: Astragalus Polysaccharides 500 mg;   Drug: Astragalus Polysaccharides 250 mgSponsor:   Taipei Medical UniversityNot yet recruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2016 Category: Research Source Type: clinical trials

Effects of PG2 on Fatigue-Related Symptom Clusters
Condition:   Cancer-related FatigueInterventions:   Drug: Astragalus Polysaccharides 500 mg;   Drug: Astragalus Polysaccharides 250 mgSponsor:   Taipei Medical UniversityRecruiting - verified April 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2016 Category: Research Source Type: clinical trials